43.73
-0.03
(-0.08%)
As of 8:00:13 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
15,190,000
15,190,000
13,860,000
13,066,000
16,207,000
Investing Cash Flow
-21,352,000
-21,352,000
-2,295,000
-1,062,000
-538,000
Financing Cash Flow
5,127,000
5,127,000
-9,416,000
-16,962,000
-16,224,000
End Cash Position
10,347,000
10,347,000
11,519,000
9,325,000
14,316,000
Capital Expenditure
-1,248,000
-1,248,000
-1,209,000
-1,118,000
-973,000
Issuance of Debt
15,969,000
15,969,000
4,455,000
6,120,000
--
Repayment of Debt
-5,873,000
-5,873,000
-3,999,000
-11,431,000
-6,022,000
Repurchase of Capital Stock
--
--
-5,155,000
-8,001,000
-6,287,000
Free Cash Flow
13,942,000
13,942,000
12,651,000
11,948,000
15,234,000
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRK.MX Merck & Co., Inc.
1,560.00
-2.80%
NOTA.BE Novartis AG
97.40
+3.18%
NOV.MU Novo Nordisk A/S
55.89
+0.47%
SNW.HM Sanofi SA
91.01
+1.03%
PFE.CL Pfizer Inc.
95,280.00
-2.60%
4AB.F AbbVie Inc.
151.60
-0.79%
NOTA.DU Novartis AG
96.00
-0.83%
BAYZF Bayer Aktiengesellschaft
23.65
0.00%
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,899.00
-1.01%
NOVA.F Novo Nordisk A/S
56.30
+3.30%